Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Individuals with integrated medical, behavioral, and pharmacy benefits are more engaged in their health, well-being

A study by global health service company Cigna Corporation (NYSE: CI) shows that individuals whose medical, behavioral and pharmacy health benefits are connected and administered by Cigna are more engaged in their health and well-being than those whose benefits are not fully integrated across medical, behavioral and pharmacy.

30 Oct 2018

UTHealth's Valentin Dragoi wins $1.6 million NIH award to unlock mysteries of the brain

Working to further the understanding of how the brain processes information, Valentin Dragoi, Ph.D., of The University of Texas Health Science Center at Houston has been awarded a three-year, $1.6 million award from the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies Initiative.

30 Oct 2018

Study examines effects of walking exercise training on cognitive function in people with MS

John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, has received a $95,000 sub-award from EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.

29 Oct 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Stroke specialists often see conditions known as stroke "mimics" and "chameleons" that can complicate accurate diagnoses, Loyola Medicine neurologists report in the November 2018 issue of Neuroimaging Clinics of North America.

26 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

Conceptual framework proposed to examine role of exercise in multiple sclerosis

Researchers have proposed a conceptual framework for examining the relationship between exercise and adaptive neuroplasticity in the population with multiple sclerosis (MS).

19 Oct 2018

Research points to new target for treating periodontitis

T cells help fight off infection, but they can go overboard. A new study led by researchers at the University of Pennsylvania School of Dental Medicine and the National Institutes of Health shows that a subset of T cells contributes to the problematic inflammation and bone loss that is associated with periodontitis, a severe form of gum disease.

17 Oct 2018

Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation

A group of Massachusetts General Hospital investigators is proposing that targeting immune checkpoints - molecules that regulate the activity of the immune system - in immune cells called microglia could reduce the inflammatory aspects of important neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

17 Oct 2018

Expanding the knowledge about hippocampus to better understand cognitive deficits in MS

A recent article by a team of international experts on multiple sclerosis (MS) underscores the importance of expanding the knowledge base about the hippocampus in order to better understand the genesis of cognitive deficits and develop new treatment strategies.

17 Oct 2018

Environmental conditions may drive development of multiple sclerosis

A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.

16 Oct 2018

Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration

Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier--which keeps large molecules in the blood from entering the brain--becomes abnormally permeable, allowing fibrin to leak into the brain and trigger inflammation.

16 Oct 2018

New patient-centric website launched in Europe to empower people with chronic conditions

Teva Pharmaceutical Industries Ltd. today announced the European launch of Life Effects (https://lifeeffects.teva), a patient-centric website hosting content created by patients and checked by experts, at the European Committee for the Treatment and Research of Multiple Sclerosis Congress in Berlin.

12 Oct 2018

Gut microbiota could play greater role in pathogenesis of MS than previously thought

In multiple sclerosis, a defective response of the body’s own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed, researchers at the University of Zurich have now found.

11 Oct 2018

Teva announces European launch of patient-centric website

Teva Pharmaceutical Industries Ltd. today announced the European launch of Life Effects, a patient-centric website hosting content created by patients and checked by experts, at the European Committee for the Treatment and Research of Multiple Sclerosis Congress in Berlin.

11 Oct 2018

Will Maine voters decide to make aging in place affordable?

As Election Day draws near, a ballot initiative in Maine to provide universal home care is shining a spotlight on the inadequacies of the nation's long-term care system.

11 Oct 2018

UK Biobank provides wealth of information for further genetic studies

There are 3.2 billion positions on the human genome and it requires a study of huge number of genetic variations in the populations to estimate the associations between genetic disorders and mutations. Two new studies have been published in the journal Nature.

11 Oct 2018

Study highlights sex differences in 'thermal behavior'

New research from the University at Buffalo has, for the first time, identified differences between men and women in their preferences for maintaining comfort both while exercising and in recovery. The results could one day inform the development of new athletic apparel.

10 Oct 2018

New project aims to improve long-term patient monitoring through remote assessment

Under conventional medical practice, monitoring long-term patients is done in the clinic or hospital, assessing such things as treatment effects, adverse events and disease course.

9 Oct 2018

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Novartis today announced that both the US Food and Drug Administration and European Medicines Agency have accepted the company's New Drug Application and Marketing Authorization Application respectively, for investigational oral, once-daily siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis in adults.

8 Oct 2018

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Individuals with integrated medical, behavioral, and pharmacy benefits are more engaged in their health, well-being

UTHealth's Valentin Dragoi wins $1.6 million NIH award to unlock mysteries of the brain

Study examines effects of walking exercise training on cognitive function in people with MS

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Conceptual framework proposed to examine role of exercise in multiple sclerosis

Research points to new target for treating periodontitis

Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation

Expanding the knowledge about hippocampus to better understand cognitive deficits in MS

Environmental conditions may drive development of multiple sclerosis

Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration

New patient-centric website launched in Europe to empower people with chronic conditions

Gut microbiota could play greater role in pathogenesis of MS than previously thought

Teva announces European launch of patient-centric website

Will Maine voters decide to make aging in place affordable?

UK Biobank provides wealth of information for further genetic studies

Study highlights sex differences in 'thermal behavior'

New project aims to improve long-term patient monitoring through remote assessment

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in